9713 related articles for article (PubMed ID: 1951881)
1. The prognostic implications of location for scalp melanoma.
Shumate CR; Carlson GW; Giacco GG; Guinee VF; Byers RM
Am J Surg; 1991 Oct; 162(4):315-9. PubMed ID: 1951881
[TBL] [Abstract][Full Text] [Related]
2. Melanoma of the scalp: the invisible killer.
Benmeir P; Baruchin A; Lusthaus S; Weinberg A; Ad-El D; Nahlieli O; Neuman A; Wexler MR
Plast Reconstr Surg; 1995 Mar; 95(3):496-500. PubMed ID: 7870773
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous melanoma. Prognostic classification of anatomic location.
Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
[TBL] [Abstract][Full Text] [Related]
4. Anatomic location of primary melanoma: Survival differences and sun exposure.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Am Acad Dermatol; 2019 Aug; 81(2):500-509. PubMed ID: 31009667
[TBL] [Abstract][Full Text] [Related]
5. Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study.
Xie C; Pan Y; McLean C; Mar V; Wolfe R; Kelly J
J Am Acad Dermatol; 2017 Mar; 76(3):494-498.e2. PubMed ID: 28413056
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in head and neck melanoma. Effect of lesion location.
Wanebo HJ; Cooper PH; Young DV; Harpole DH; Kaiser DL
Cancer; 1988 Aug; 62(4):831-7. PubMed ID: 3395962
[TBL] [Abstract][Full Text] [Related]
7. Melanoma of the Foot Is Associated With Advanced Disease and Poorer Survival.
Adams BE; Peng PD; Williams ML
J Foot Ankle Surg; 2018; 57(1):52-55. PubMed ID: 29037928
[TBL] [Abstract][Full Text] [Related]
8. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.
Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2484-91. PubMed ID: 7736392
[TBL] [Abstract][Full Text] [Related]
10. BANS: a discussion of the problem.
Bernengo MG; Reali UM; Doveil GC; Cappello N; Lisa F; Moretti S
Melanoma Res; 1992 Sep; 2(3):157-62. PubMed ID: 1450669
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
[TBL] [Abstract][Full Text] [Related]
12. Experience with 998 cutaneous melanomas of the head and neck over 30 years.
O'Brien CJ; Coates AS; Petersen-Schaefer K; Shannon K; Thompson JF; Milton GW; McCarthy WH
Am J Surg; 1991 Oct; 162(4):310-4. PubMed ID: 1951880
[TBL] [Abstract][Full Text] [Related]
13. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
[TBL] [Abstract][Full Text] [Related]
14. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
[TBL] [Abstract][Full Text] [Related]
15. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
Law MM; Wong JH
Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088
[TBL] [Abstract][Full Text] [Related]
19. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
20. Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas.
Patuzzo R; Maurichi A; Camerini T; Gallino G; Ruggeri R; Baffa G; Mattavelli I; Tinti MC; Crippa F; Moglia D; Tolomio E; Maccauro M; Santinami M
J Surg Res; 2014 Apr; 187(2):518-24. PubMed ID: 24252855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
